The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Ligand-targeted therapeutics in anticancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer
Behr, T. M., Liersch, T., Greiner‐Bechert, L., Griesinger, F., Béhé, M. P., Markus, P. M., Gratz, S., Angerstein, C., Brittinger, G., Heinz Becker, A., et al. (2002) · Cancer · doi:10.1002/cncr.10308 · Cited by 110
RetractedContinuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Witzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,170
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Sievers, E. L., Larson, R. A., Stadtmauer, E. A., Estey, E., Löwenberg, B., Dombret, H., Karanes, C., Theobald, M., Bennett, J. M., Sherman, M. L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3244 · Cited by 899
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Cited by
Items 101–157 of 157
Li, X., Kim, C.-Y., Lee, S., Lee, D., Chung, H.-M., Kim, G., Heo, S.-H., Kim, C., Hong, K.-S., & Yoon, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05916 · Cited by 343
Advancement and applications of peptide phage display technology in biomedical science
Wu, C.-H., Liu, I.-J., Lu, R.-M., & Wu, H.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 339
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Nanoparticles as carriers for drug delivery in cancer
Dadwal, A., Baldi, A., & Kumar Narang, R. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1457039 · Cited by 335
Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Polymeric microneedles for transdermal protein delivery
Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.015 · Cited by 324
Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics
Lee, M. H., Sharma, A., Chang, M. J., Lee, J., Son, S., Sessler, J. L., Kang, C., & Kim, J. S. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00557a · Cited by 317
Mimicking the Cell: Bio-Inspired Functions of Supramolecular Assemblies
Tu, Y., Peng, F., Adawy, A., Men, Y., Abdelmohsen, L. K. E. A., & Wilson, D. A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00344 · Cited by 316
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
Emerich, D. F., & Thanos, C. G. (2006) · Biomolecular Engineering · doi:10.1016/j.bioeng.2006.05.026 · Cited by 312
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Liposome-based drug co-delivery systems in cancer cells
Zununi Vahed, S., Salehi, R., Davaran, S., & Sharifi, S. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.073 · Cited by 307
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Deng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T. K. H., & Tang, T. (2014) · Gene · doi:10.1016/j.gene.2013.12.019 · Cited by 301
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Avramović, N., Mandić, B., Savić-Radojević, A., & Simić, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040298 · Cited by 296
Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting
Park, J., von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Small · doi:10.1002/smll.200801789 · Cited by 293
Rowe, M. D., Thamm, D. H., Kraft, S. L., & Boyes, S. G. (2009) · Biomacromolecules · doi:10.1021/bm900043e · Cited by 286
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280
Chen, K.-J., Liang, H.-F., Chen, H.-L., Wang, Y., Cheng, P.-Y., Liu, H.-L., Xia, Y., & Sung, H.-W. (2013) · ACS Nano · doi:10.1021/nn304474j · Cited by 279
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Sun, B., Ranganathan, B., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.038 · Cited by 274
Pearce, A. K., & O’Reilly, R. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00456 · Cited by 275
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Rommasi, F., & Esfandiari, N. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03553-8 · Cited by 269
Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy
Zhang, C., Wang, W., Liu, T., Wu, Y., Guo, H., Wang, P., Tian, Q., Wang, Y., & Yuan, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.045 · Cited by 268
Chitosan-based siRNA delivery systems
Ragelle, H., Vandermeulen, G., & Préat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.005 · Cited by 261
A Designed Ankyrin Repeat Protein Evolved to Picomolar Affinity to Her2
Zahnd, C., Wyler, E., Schwenk, J. M., Steiner, D., Lawrence, M. C., McKern, N. M., Pecorari, F., Ward, C. W., Joos, T. O., & Plückthun, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.028 · Cited by 256
Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems
Narmani, A., Rezvani, M., Farhood, B., Darkhor, P., Mohammadnejad, J., Amini, B., Refahi, S., & Abdi Goushbolagh, N. (2019) · Drug Development Research · doi:10.1002/ddr.21545 · Cited by 255
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Qhattal, H. S. S., & Liu, X. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000428 · Cited by 254
Disulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug Delivery
Lee, M. H., Sessler, J. L., & Kim, J. S. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00406 · Cited by 254
Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery
Li, M., Zhao, G., Su, W.-K., & Shuai, Q. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00647 · Cited by 253
“Active tumortargeting nanoparticles integrated with site-specific enzymetriggered moieties are able to significantly achieve enhanced accumulation at the tumor site, reduced undesired uptake by non-targeted tissues, as well as site-specific controlled drug release (Allen, 2002).”
BackgroundDrug delivery vehicles on a nano-engineering perspective
Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.04.049 · Cited by 253
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.056 · Cited by 242
Nanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
Targeted nanoparticles for detecting and treating cancer
Sunderland, C. J., Steiert, M., Talmadge, J. E., Derfus, A. M., & Barry, S. E. (2006) · Drug Development Research · doi:10.1002/ddr.20069 · Cited by 200
Shi, C., Guo, X., Qu, Q., Tang, Z., Wang, Y., & Zhou, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.036 · Cited by 189
Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
Zhan, Q., Yi, K., Qi, H., Li, S., Li, X., Wang, Q., Wang, Y., Liu, C., Qiu, M., Yuan, X., et al. (2020) · Theranostics · doi:10.7150/thno.45028 · Cited by 168
Abd Ellah, N. H., & Abouelmagd, S. A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1213238 · Cited by 164
The Rise and Rise of Stealth Nanocarriers for Cancer Therapy: Passive Versus Active Targeting
Huynh, N. T., Roger, E., Lautram, N., Benoît, J.-P., & Passirani, C. (2010) · Nanomedicine · doi:10.2217/nnm.10.113 · Cited by 164
Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy
Wang, J., Li, S., Han, Y., Guan, J., Chung, S., Wang, C., & Li, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00202 · Cited by 155
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Guan, J., Shen, Q., Zhang, Z., Jiang, Z., Yang, Y., Lou, M., Qian, J., Lu, W., & Zhan, C. (2018) · Nature Communications · doi:10.1038/s41467-018-05384-1 · Cited by 152
A review of polypeptide-based polymersomes
Zhao, L., Li, N., Wang, K., Shi, C., Zhang, L., & Luan, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.063 · Cited by 149
PEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137
Binding and interstitial penetration of liposomes within avascular tumor spheroids
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W., Ballangrud, Å., & Sgouros, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20457 · Cited by 127
Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
Gyanani, V., Haley, J. C., & Goswami, R. (2021) · Pharmaceuticals · doi:10.3390/ph14090835 · Cited by 118
Thermo-triggered Drug Release from Actively Targeting Polymer Micelles
Guo, X., Li, D., Yang, G., Shi, C., Tang, Z., Wang, J., & Zhou, S. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501422r · Cited by 97
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
Polito, L., Djemil, A., & Bortolotti, M. (2016) · Biomedicines · doi:10.3390/biomedicines4020012 · Cited by 75
“The pharmacologically active conjugates are primarily applied to research in the field of cancer therapy [1].”
BackgroundBiscaglia, F., Ripani, G., Rajendran, S., Benna, C., Mocellin, S., Bocchinfuso, G., Meneghetti, M., Palleschi, A., & Gobbo, M. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b01392 · Cited by 54
Federman, N., Chan, J., Nagy, J. O., Landaw, E. M., McCabe, K., Wu, A. M., Triche, T., Kang, H., Liu, B., Marks, J. D., et al. (2012) · Sarcoma · doi:10.1155/2012/126906 · Cited by 44
“Finally from a potential therapeutic delivery perspective, it is best when candidate tumor markers are internalized when bound by ligands or proteins at the cell surface [8].”
BackgroundXiong, S., Yu, B., Wu, J., Li, H., & Lee, R. J. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.10.003 · Cited by 43
Naulaerts, S., Dang, C. C., & Ballester, P. J. (2017) · Oncotarget · doi:10.18632/oncotarget.20923 · Cited by 41
Microfluidic co-culture devices to assess penetration of nanoparticles into cancer cell mass
Jarvis, M., Arnold, M., Ott, J., Pant, K., Prabhakarpandian, B., & Mitragotri, S. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10079 · Cited by 32
Functionalized Biomimetic Magnetic Nanoparticles as Effective Nanocarriers for Targeted Chemotherapy
Peigneux, A., Oltolina, F., Colangelo, D., Iglesias, G. R., Delgado, A. V., Prat, M., & Jimenez‐Lopez, C. (2019) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201900057 · Cited by 29
Gupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Zalba, S., Contreras, A. M., Merino, M., Navarro, I., de Ilarduya, C. T., Trocóniz, I. F., Koning, G., & Garrido, M. J. (2016) · Nanomedicine · doi:10.2217/nnm.15.208 · Cited by 26
Metadata
- Authors
- Allen, T. M.
- Venue
- Nature Reviews Cancer
- Published
- 2002-10
- Volume
- 2
- Issue
- 10
- Pages
- 750-763
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2041759339
- Cited by
- 1,647
- References
- 97
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.